Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
161 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 62578 |
552 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 15141 |
3061 | 1 | TAMOXIFEN//TOREMIFENE//DROLOXIFENE | 2103 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TAMOXIFEN | authKW | 1657921 | 33% | 16% | 699 |
2 | TOREMIFENE | authKW | 814301 | 5% | 54% | 100 |
3 | DROLOXIFENE | authKW | 220189 | 1% | 57% | 26 |
4 | ANTIESTROGEN | authKW | 158418 | 4% | 14% | 78 |
5 | DESMETHYLTAMOXIFEN | authKW | 74924 | 0% | 100% | 5 |
6 | GYNECOL ULTRASOUND UNIT | address | 61182 | 0% | 58% | 7 |
7 | LYNN SAGE BREAST CANC PROGRAM | address | 61182 | 0% | 58% | 7 |
8 | ENDOMETRIAL PATHOLOGY | authKW | 58109 | 1% | 26% | 15 |
9 | 4 HYDROXYTAMOXIFEN | authKW | 55985 | 1% | 19% | 20 |
10 | EM 800 | authKW | 53514 | 0% | 71% | 5 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 17495 | 47% | 0% | 998 |
2 | Obstetrics & Gynecology | 6072 | 17% | 0% | 352 |
3 | Pharmacology & Pharmacy | 786 | 14% | 0% | 285 |
4 | Endocrinology & Metabolism | 733 | 8% | 0% | 175 |
5 | Toxicology | 676 | 6% | 0% | 128 |
6 | Chemistry, Medicinal | 187 | 4% | 0% | 75 |
7 | Reproductive Biology | 141 | 2% | 0% | 41 |
8 | Medicine, General & Internal | 88 | 5% | 0% | 100 |
9 | Ophthalmology | 63 | 2% | 0% | 45 |
10 | Chemistry, Analytical | 39 | 3% | 0% | 73 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | GYNECOL ULTRASOUND UNIT | 61182 | 0% | 58% | 7 |
2 | LYNN SAGE BREAST CANC PROGRAM | 61182 | 0% | 58% | 7 |
3 | ALFRED G KNUDSON CHAIR CANC | 46824 | 0% | 63% | 5 |
4 | CANCBREAST CANC DIS PROGRAMDANA FARBER HARV | 29970 | 0% | 100% | 2 |
5 | TRANSGEN ANIM MOL MED | 29970 | 0% | 100% | 2 |
6 | AEGEAN OBSTET GYNECOL TEACHING HOSP | 14985 | 0% | 100% | 1 |
7 | ANAL ANTIDOPING | 14985 | 0% | 100% | 1 |
8 | ANALYSE STAT | 14985 | 0% | 100% | 1 |
9 | B T ONCOL | 14985 | 0% | 100% | 1 |
10 | BIOPATHOLSECT PATHOL ANAT | 14985 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BREAST CANCER RESEARCH AND TREATMENT | 14777 | 4% | 1% | 86 |
2 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 6313 | 2% | 1% | 36 |
3 | CARCINOGENESIS | 5836 | 3% | 1% | 68 |
4 | EUROPEAN JOURNAL OF CANCER | 5749 | 3% | 1% | 63 |
5 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 4730 | 3% | 1% | 54 |
6 | GYNECOLOGIC ONCOLOGY | 4135 | 3% | 0% | 57 |
7 | CHEMICAL RESEARCH IN TOXICOLOGY | 3826 | 2% | 1% | 37 |
8 | CANCER RESEARCH | 2442 | 4% | 0% | 82 |
9 | PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH | 1659 | 0% | 4% | 3 |
10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1632 | 1% | 0% | 29 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TAMOXIFEN | 1657921 | 33% | 16% | 699 | Search TAMOXIFEN | Search TAMOXIFEN |
2 | TOREMIFENE | 814301 | 5% | 54% | 100 | Search TOREMIFENE | Search TOREMIFENE |
3 | DROLOXIFENE | 220189 | 1% | 57% | 26 | Search DROLOXIFENE | Search DROLOXIFENE |
4 | ANTIESTROGEN | 158418 | 4% | 14% | 78 | Search ANTIESTROGEN | Search ANTIESTROGEN |
5 | DESMETHYLTAMOXIFEN | 74924 | 0% | 100% | 5 | Search DESMETHYLTAMOXIFEN | Search DESMETHYLTAMOXIFEN |
6 | ENDOMETRIAL PATHOLOGY | 58109 | 1% | 26% | 15 | Search ENDOMETRIAL+PATHOLOGY | Search ENDOMETRIAL+PATHOLOGY |
7 | 4 HYDROXYTAMOXIFEN | 55985 | 1% | 19% | 20 | Search 4+HYDROXYTAMOXIFEN | Search 4+HYDROXYTAMOXIFEN |
8 | EM 800 | 53514 | 0% | 71% | 5 | Search EM+800 | Search EM+800 |
9 | SERM | 47628 | 1% | 10% | 31 | Search SERM | Search SERM |
10 | TAS 108 | 44954 | 0% | 100% | 3 | Search TAS+108 | Search TAS+108 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |